semaglutide 2.4 mg obesity 2·4 once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial A major healthcare shift starts

Regular monitoring should include weight checks, renal function, gastrointestinal symptoms, and coordination with haematology-oncology teams

In the placebo group, only waist circumference, and not body weight, showed a similar association

May 04, 2025 | 10:10 AM Understanding GLP-1 Safety: Guidelines, Best Practices, and Emerging Trends GLP-1 medications have quickly become some of the most talked-about treatments in health and wellness circles

CAR T-Cell Therapy CAR T-cell therapy is an advanced treatment that enhances your immune systems ability to recognize and attack cancer cells

They are not FDA-approved as finished products, but 503A compounds are legal, regulated, and pharmacologically identical to brand-name counterparts